Cargando…

Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment

The mortality rate of critically ill patients with acute respiratory distress syndrome (ARDS) is 30.9% to 46.1%. The emergence of the coronavirus disease 2019 (Covid-19) has become a global issue with raising dire concerns. Patients with severe Covid-19 may progress toward ARDS. Mesenchymal stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wendi, Lei, Wei, Jiang, Lina, Gao, Siqi, Hu, Shijun, Zhao, Zi-Gang, Niu, Chun-Yu, Zhao, Zhen-Ao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107778/ https://www.ncbi.nlm.nih.gov/pubmed/33971907 http://dx.doi.org/10.1186/s12967-021-02862-x

Ejemplares similares

Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
por: Zhao, Xuan, et al.
Publicado: (2020)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application
por: Freitag, Julien, et al.
Publicado: (2020)

Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges
por: Cao, Chao, et al.
Publicado: (2022)

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
por: Qin, Hua, et al.
Publicado: (2020)

RUNX1 mediates the therapeutic effects of mesenchymal stem cells‐derived microparticles in acute respiratory distress syndrome
por: Predescu, Dan, et al.
Publicado: (2023)

MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2017)

Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome
por: Xu, Amy L., et al.
Publicado: (2019)

Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome
por: Liang, Tian-Yu, et al.
Publicado: (2023)

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019)

The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
por: Guo, Yajun, et al.
Publicado: (2020)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Mesenchymal Stem Cell–derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation–supported Acute Respiratory Distress Syndrome?
por: Zhang, Lanyu, et al.
Publicado: (2020)

Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome
por: Luo, Yuling, et al.
Publicado: (2023)

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016)

The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018)

Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome?
por: Yilmaz, Sema, et al.
Publicado: (2012)

Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020)

Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment
por: Sun, Hao, et al.
Publicado: (2022)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

Current therapeutic strategies for respiratory diseases using mesenchymal stem cells
por: Wang, Ming‐yao, et al.
Publicado: (2021)

Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease
por: Zargar, Mehdi Jahedi, et al.
Publicado: (2022)

Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis
por: Hu, Jianxia, et al.
Publicado: (2016)

Reply to Zhang and Hei: Mesenchymal Stem Cell–derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation–supported Acute Respiratory Distress Syndrome?
por: Millar, Jonathan E., et al.
Publicado: (2020)

Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
por: Zhuang, Xiaoli, et al.
Publicado: (2023)

Mesenchymal stem cells with downregulated Hippo signaling attenuate lung injury in mice with lipopolysaccharide-induced acute respiratory distress syndrome
por: Li, Lang, et al.
Publicado: (2019)

A Bibliometric Analysis of Mesenchymal Stem Cell-Derived Exosomes in Acute Lung Injury/Acute Respiratory Distress Syndrome from 2013 to 2022
por: Zhou, Wenyu, et al.
Publicado: (2023)

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
por: Lin, Feng, et al.
Publicado: (2020)

Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Supported with Extracorporeal Membrane Oxygenation. Lost in Translational Research?
por: Del Sorbo, Lorenzo, et al.
Publicado: (2020)

Increased mobilization of mesenchymal stem cells in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation
por: Patry, Christian, et al.
Publicado: (2020)

Treatment of Acute Respiratory Distress Syndrome Caused by COVID-19 with Human Umbilical Cord Mesenchymal Stem Cells
por: Bukreieva, Tetiana, et al.
Publicado: (2023)

Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options
por: Pierrakos, Charalampos, et al.
Publicado: (2012)

RNAi therapeutic strategies for acute respiratory distress syndrome
por: Jagrosse, Melissa L., et al.
Publicado: (2019)

Definition of Acute Respiratory Distress Syndrome on the Plateau of Xining, Qinghai: A Verification of the Berlin Definition Altitude-PaO(2)/FiO(2)-Corrected Criteria
por: Liu, Xiaoqin, et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cells: SAFETY OF CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS IN COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME
por: Shaz, B., et al.
Publicado: (2022)

Protease Activated Receptors: A Pathway to Boosting Mesenchymal Stromal Cell Therapeutic Efficacy in Acute Respiratory Distress Syndrome?
por: Gupta, Naveen
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_irci99d1t3iraenu76v3a09pni